News
Verseon Corporation - Verseon presents data on DME program at BIO 2017
RNS Number: 0785 J Verseon Corporation 26 June 2017 Press release June 26, 2017. Verseon presents preclinical data on diabetic macular edema candidates at BIO 2017. Fremont, Calif.-Verseon presented pharmacokinetic and in vivo efficacy data on its diabetic macular edema candidates at the 2017 BIO International Conference last week.
RNS Number: 0785 J Verseon Corporation 26 June 2017 Press release June 26, 2017. Verseon presents preclinical data on diabetic macular edema candidates at BIO 2017. Fremont, Calif.-Verseon presented pharmacokinetic and in vivo efficacy data on its diabetic macular edema candidates at the 2017 BIO International Conference last week.